Culprit Lesion Only PCI Versus Multivessel PCI in Cardiogenic Shock (CULPRIT-SHOCK)
Prospective Randomized Multicenter Study Comparing Immediate Multivessel Revascularization by PCI Versus Culprit Lesion PCI With Staged Non-culprit Lesion Revascularization in Patients With Acute Myocardial Infarction Complicated by Cardiogenic Shock
Sponsor: Deutsche Stiftung für Herzforschung
A PHASE4 clinical study on Acute Myocardial Infarction and Cardiogenic Shock, this trial is completed. The trial is conducted by Deutsche Stiftung für Herzforschung and has accumulated 7 data snapshots since 2013. Cardiovascular trials of this type often inform treatment guidelines for long-term patient management.
Status Flow
Change History
7 versions recorded-
Sep 2025 — Present [monthly]
Completed PHASE4
-
Sep 2024 — Sep 2025 [monthly]
Completed PHASE4
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE4
-
Jan 2021 — Jul 2024 [monthly]
Completed PHASE4
-
Jun 2018 — Jan 2021 [monthly]
Completed PHASE4
▶ Show 2 earlier versions
-
Dec 2017 — Jun 2018 [monthly]
Completed PHASE4
Status: Recruiting → Completed
-
Jan 2017 — Dec 2017 [monthly]
Recruiting PHASE4
First recorded
Apr 2013
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Deutsche Stiftung für Herzforschung
- Deutsches Zentrum für Herz-Kreislauf-Forschung (DZHK)
- European Commission
- German Cardiac Society
- University of Luebeck
For direct contact, visit the study record on ClinicalTrials.gov .